BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 466927)

  • 1. Hemodynamic effects of intravenous timolol in coronary artery disease.
    Chew CY; Collett J; Shah PK; Singh BN
    Clin Pharmacol Ther; 1979 Sep; 26(3):330-8. PubMed ID: 466927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular performance and pulmonary circulation following addition of nitrous oxide to morphine during coronary-artery surgery.
    Lappas DG; Buckley MJ; Laver MB; Daggett WM; Lowenstein E
    Anesthesiology; 1975 Jul; 43(1):61-9. PubMed ID: 1147309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous verapamil on hemodynamics in patients with heart disease.
    Singh BN; Roche AH
    Am Heart J; 1977 Nov; 94(5):593-9. PubMed ID: 333889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and coronary hemodynamic effects of beta-adrenoceptor blocking agents in coronary artery disease.
    Yabe Y; Morishita T
    Jpn Heart J; 1987 Sep; 28(5):675-86. PubMed ID: 3430729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemodynamic effects of intravenous tocainide in patients with heart disease.
    Winkle RA; Anderson JL; Peters F; Meffin PJ; Fowles RE; Harrison DC
    Circulation; 1978 Apr; 57(4):787-92. PubMed ID: 630689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
    Atkins CE; Keene BW; McGuirk SM; Sato T
    Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct cardiac and peripheral vascular effects of intracoronary and intravenous nifedipine.
    Terris S; Bourdillon PD; Cheng DT; Pitt B
    Am J Cardiol; 1986 Jul; 58(1):25-30. PubMed ID: 3728327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic effects of intravenous injections of amiodarone chlorhydrate in normal subjects and coronary patients].
    Ourbak P; Rocher R; Aziza JP; Manin JP; Vagner D; Leclerc M; Maurice P
    Arch Mal Coeur Vaiss; 1976 Mar; 69(3):293-8. PubMed ID: 828014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic effects of intravenous nicardipine in patients treated chronically with propranolol for coronary artery disease.
    Rocha P; Zannier D; Baron B; Pathe M; David D; Kahn JC
    Am J Cardiol; 1987 Apr; 59(8):775-81. PubMed ID: 3825937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
    Pornin M; Harpey C; Allal J; Sellier P; Ourbak P
    Clin Trials Metaanal; 1994 Apr; 29(1):49-56. PubMed ID: 10150185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in man.
    Hillis WS; Hutton I; Lawrie TD; Lorimer AR; Reid JM
    Br J Pharmacol; 1974 May; 51(1):15-9. PubMed ID: 4155334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemodynamic effects of intravenous encainide in patients with heart disease.
    Tucker CR; Winkle RA; Peters FA; Harrison DC
    Am Heart J; 1982 Aug; 104(2 Pt 1):209-15. PubMed ID: 6808816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of esmolol on patients with left ventricular dysfunction.
    Iskandrian AS; Bemis CE; Hakki AH; Panidis I; Heo J; Toole JG; Hua TA; Allin D; Kane-Marsch S
    J Am Coll Cardiol; 1986 Jul; 8(1):225-31. PubMed ID: 2872244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of intravenous metoprolol.
    Bourdillon PD; Canepa-Anson R; Rickards AF
    Am J Cardiol; 1979 Nov; 44(6):1195-200. PubMed ID: 495515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
    Gagnon RM; Morissette M; Présant S; Savard D; Lemire J
    Am J Cardiol; 1982 Apr; 49(5):1267-9. PubMed ID: 7064851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma timolol levels and systolic time intervals.
    Singh BN; Williams FM; Whitlock RM; Collett J; Chew C
    Clin Pharmacol Ther; 1980 Aug; 28(2):159-66. PubMed ID: 7398183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of morphine and pentazocine differ in cardiac patients.
    Alderman EL; Barry WH; Graham AF; Harrison DC
    N Engl J Med; 1972 Sep; 287(13):623-7. PubMed ID: 4561828
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemodynamic, reflexive, and metabolic alterations induced by acute and chronic timolol therapy in hypertensive man.
    Dunn FG; de Carvalho JG; Frohlich ED
    Circulation; 1978 Jan; 57(1):140-4. PubMed ID: 618381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative effects of propranolol and timolol on ventricular fibrillation threshold and hemodynamics in the dog.
    Nanas JN; Kralios AC
    Am Heart J; 1986 Jun; 111(6):1094-100. PubMed ID: 3716983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.